AZ&Me Prescription Savings Program
Run by AstraZeneca Pharmaceuticals LP
AZ&Me Prescription Savings Program, run by AstraZeneca Pharmaceuticals LP, provides the medication at no cost if you qualify. One eligibility path: "You don't have insurance (or only have Medicare)."
At a glance
- Run by
- AstraZeneca Pharmaceuticals LP
- Status
- Verified
- Last verified
- 08/18/26
- Medicare
- Has a Medicare eligibility path.
- Confirmed medications
- 3
- Coverage unconfirmed
- 15
Phone 1-800-292-6363
Income limits and eligibility paths
Review each published path and its conditions. A path may apply only to certain medications or insurance coverage.
You don't have insurance (or only have Medicare)
300% FPL applies to Primary and Specialty Medications (nearly all AZ&Me drugs). Rare Disease Medications (currently WAINUA only) use a separate 500% FPL tier — see the 'rare-disease-drug' extra condition below. 48-state dollar table (effective 2026-01-26): 1p $47,880, 2p $64,920, 3p $81,960, 4p $99,000, 5p $116,040, 6p $133,080, 7p $150,120, 8p $167,160. Alaska and Hawaii use higher published tables.
Income basis
300% of the federal poverty level
Calculated from the 2026 federal poverty guidelines for the 48 contiguous states and DC. These figures do not apply to Alaska or Hawaii. Confirm regional and larger-household amounts with the program.
You have Medicare but don't qualify for Extra Help (LIS)
Same 300%/500% FPL split by medication category as the no-insurance track (this is the SAME income rule applied to a distinct insurance-status population — Medicare beneficiaries, rather than the fully uninsured).
Income basis
300% of the federal poverty level
Calculated from the 2026 federal poverty guidelines for the 48 contiguous states and DC. These figures do not apply to Alaska or Hawaii. Confirm regional and larger-household amounts with the program.
Insurance and other requirements
Each path has its own conditions. Read the complete requirements and confirm which path applies to you.
-
Path 1
You don't have insurance (or only have Medicare)
Insurance category: no-insurance
- ·300% FPL applies to Primary and Specialty Medications (nearly all AZ&Me drugs). Rare Disease Medications (currently WAINUA only) use a separate 500% FPL tier — see the 'rare-disease-drug' extra condition below. 48-state dollar table (effective 2026-01-26): 1p $47,880, 2p $64,920, 3p $81,960, 4p $99,000, 5p $116,040, 6p $133,080, 7p $150,120, 8p $167,160. Alaska and Hawaii use higher published tables.
- ·Must not have any commercial (private or employer-sponsored) insurance, and no government insurance other than Medicare.
- ·Must not be receiving any other form of medication assistance (stacking prohibition).
- ·For Rare Disease Medications (WAINUA), the income limit is 500% FPL instead of 300% FPL: 48-state table 1p $79,800, 2p $108,200, 3p $136,600, 4p $165,000, 5p $193,400, 6p $221,800, 7p $250,200, 8p $278,600.
- ·A 'Change in Circumstance' exception (job loss, income change, insurance loss, household-size change) can reopen eligibility outside normal criteria.
-
Path 2
You have Medicare but don't qualify for Extra Help (LIS)
Insurance category: medicare
- ·Same 300%/500% FPL split by medication category as the no-insurance track (this is the SAME income rule applied to a distinct insurance-status population — Medicare beneficiaries, rather than the fully uninsured).
- ·Patient must be covered by Medicare but must NOT be eligible for or enrolled in Medicare's Extra Help / Low-Income Subsidy (LIS) for Part D
- ·this is a blanket LIS-ineligibility requirement with no FPL carve-out stated (contrast: AbbVie only requires proof of LIS denial below 150% FPL).
- ·Must not have any commercial insurance other than Medicare.
- ·Must not be receiving any other form of medication assistance (stacking prohibition).
- ·For Rare Disease Medications (WAINUA), the income limit is 500% FPL instead of 300% FPL (same split as the no-insurance track).
What this program covers
3 confirmed covered, 18 documented exclusions and 15 unconfirmed associations. Check the category before relying on a medication link.
Covered medications
- BEVESPI Covered · 08/17/26
- BREZTRI Covered · 08/17/26
- FASENRA Pen Covered · 08/17/26
Confirmed covered associations. The program’s eligibility rules still apply.
Not on this program's current list
- Farxiga Not covered · 08/19/26
- Xigduo XR Not covered · 08/19/26
- Brilinta Not covered · 08/19/26
- Faslodex Not covered · 08/20/26
- Iressa Not covered · 08/20/26
- Koselugo Not covered · 08/20/26
- Pulmicort Flexhaler Not covered · 08/20/26
- Andexxa Not covered · 08/20/26
- Byetta Not covered · 08/20/26
- Crestor Not covered · 08/20/26
- Daliresp Not covered · 08/20/26
- Nexium Not covered · 08/20/26
- Seroquel Not covered · 08/20/26
- Soliris Not covered · 08/20/26
- Strensiq Not covered · 08/20/26
- Symbicort Not covered · 08/20/26
- Ultomiris Not covered · 08/20/26
- Voydeya Not covered · 08/20/26
These exclusions refer to this program only. They do not prove that all other help is unavailable.
Coverage unconfirmed
- Airsupra Unknown
- Bevespi Aerosphere Unknown
- Breztri Aerosphere Unknown
- Calquence Unknown
- Fasenra Unknown
- Imfinzi Unknown
- Imjudo Unknown
- Lokelma Unknown
- Lynparza Unknown
- Saphnelo Unknown
- Tagrisso Unknown
- ETCAMAH Unknown
- Wainua Unknown
- Baxfendy Unknown
- Truqap Unknown
Our records link these medications to this program, but we do not have enough evidence to confirm coverage. Contact the program before relying on this association.
How to apply
Continue to the official program website ↗
Use the program’s official application. Required documents, approval periods and renewal rules vary.
Keep your approval notice. It explains when assistance ends and what to do if renewal is required.
-
1
Check the official application
Confirm medication coverage and the eligibility path that fits your situation.
-
2
Gather the required documents
Use the income and insurance documents requested by the current form.
-
3
Coordinate with your prescriber
Ask whether clinical information, a prescription or a signature is required.
-
4
Submit and follow up
Confirm receipt and ask about the decision, approval period and renewal rules.
If this is more than you want to take on
Help with the application paperwork
You can follow the official application instructions yourself. If you choose paid help, ask which documents and follow-up tasks the fee includes.
Compare current pricing, cancellation terms and available reviews. Paying for paperwork does not establish eligibility or guarantee approval.
- Ask which forms the service prepares and submits
- Ask how the service works with your prescriber
- Check whether renewal assistance is included
Paid paperwork help is optional. Confirm the official program’s requirements first.
What changed
Changes to this program’s rules, from newest to oldest, based on its published information.
08/19/26 AZ&Me stopped accepting new patients for FARXIGA on May 1, 2026. The program's own homepage states this in its Important Program Updates banner. Patients already enrolled should contact the program directly; the banner speaks only to NEW patients and does not say existing enrollment ends.
08/19/26 AZ&Me stopped accepting new patients for XIGDUO XR on May 1, 2026, per the program's own Important Program Updates banner. Patients already enrolled should contact the program directly; the banner speaks only to NEW patients.
08/19/26 BRILINTA is no longer available through AZ&Me as of January 1, 2026, per the program's own Important Program Updates banner. This is a full withdrawal from the program, not a closure to new patients only.
Documents we track
Program document
Available on the program’s official website, last checked 08/18/26. Confirm current requirements at: https://www.azandmeapp.com/.
This link points to the program’s own document. Check the record’s verification status and confirm current terms.
What changed on this record
AZ&Me Prescription Savings Program requirements read and verified; tracking began.
AZ&Me stopped accepting new patients for FARXIGA on May 1, 2026. The program's own homepage states this in its Important Program Updates banner. Patients already enrolled should contact the program directly; the banner speaks only to NEW patients and does not say existing enrollment ends.
AZ&Me stopped accepting new patients for XIGDUO XR on May 1, 2026, per the program's own Important Program Updates banner. Patients already enrolled should contact the program directly; the banner speaks only to NEW patients.
BRILINTA is no longer available through AZ&Me as of January 1, 2026, per the program's own Important Program Updates banner. This is a full withdrawal from the program, not a closure to new patients only.